UPDATE 2-Novartis gains U.S. approval for delayed MS drug
February 13, 2018 at 08:56 AM EST
* U.S. pricing pressure weighing on Sandoz (Adds Teva comment, share price reaction)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.